Cargando…
Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients – A lifetime analysis
OBJECTIVE: Repetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of Major Depressive Disorder (MDD) after patients have failed to benefit from trials of multiple antidepressant medications. No analysis to date has examined the cost-effectiveness of rTMS used earlier...
Autores principales: | Voigt, Jeffrey, Carpenter, Linda, Leuchter, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658110/ https://www.ncbi.nlm.nih.gov/pubmed/29073256 http://dx.doi.org/10.1371/journal.pone.0186950 |
Ejemplares similares
-
A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder
por: Voigt, Jeffrey, et al.
Publicado: (2019) -
Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis
por: Voigt, Jeffrey D., et al.
Publicado: (2021) -
Factors associated with antidepressant responses to repetitive transcranial magnetic stimulation in antidepressant-resistant depression
por: Li, Cheng-Ta, et al.
Publicado: (2022) -
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
por: Zemplényi, Antal, et al.
Publicado: (2022) -
Rumination symptoms in treatment-resistant major depressive disorder, and outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) treatment
por: Chu, Stephanie A., et al.
Publicado: (2023)